Sort
16,300 grants matching “fatty liver disease”
Roles for microRNA-122 in hepatitis C virus RNA amplification
$368,488Peter Sarnow · Stanford University · R01 · FY2013 · AI
Role of the hepatic GABA shunt in insulin resistance and hyperinsulinemia
$368,400Benjamin Jennings Renquist · University Of Arizona · R01 · FY2024 · DK
Lifespan Extension Despite Greatly Elevated Insulin and Body Fat
$368,385David E Harrison · Jackson Laboratory · R01 · FY2010 · AG
Macrophage-specific targeting of LXRs in CVD and NASH
$368,384Christopher K Glass · University Of California, San Diego · P01 · FY2021 · HL
Pivotal Role of Oxidation-specific Epitopes in CVD and NASH.
$368,382Joseph L Witztum · University Of California, San Diego · P01 · FY2021 · HL
Structure and Function of Enzymes in Fatty Acid Oxidation
$368,372Jung Ja P. Kim · Medical College Of Wisconsin · R01 · FY2013 · GM
Macrophage-specific targeting of LXRs in CVD and NASH
$368,371Christopher K Glass · University Of California, San Diego · P01 · FY2023 · HL
Pivotal Role of Oxidation-specific Epitopes in CVD and NASH.
$368,369Joseph L Witztum · University Of California, San Diego · P01 · FY2023 · HL
Mechanisms regulating lipoprotein secretion and lipid metabolism
$368,337Hongmin Ni · University Of Kansas Medical Center · R01 · FY2025 · DK
Redox control of hepatic lipid metabolism
$368,325Markus Michael Bachschmid · Boston University Medical Campus · R01 · FY2016 · DK
Redox control of hepatic lipid metabolism
$368,325Markus Michael Bachschmid · Boston University Medical Campus · R01 · FY2018 · DK
Redox Control of Hepatic Lipid Metabolism
$368,325Markus Michael Bachschmid · Boston University Medical Campus · R01 · FY2019 · DK
Redox control of hepatic lipid metabolism
$368,325Markus Michael Bachschmid · Boston University Medical Campus · R01 · FY2015 · DK
Redox control of hepatic lipid metabolism
$368,325Markus Michael Bachschmid · Boston University Medical Campus · R01 · FY2017 · DK
Regulation of Circadian Metabolism by the Hepatic Transcription Factor CREBH
$368,275Kezhong Zhang · Wayne State University · R01 · FY2018 · DK
FAK regulation of cholesterol influx and efflux in foam cells
$368,232Steve Lim · University Of Alabama At Birmingham · R01 · FY2024 · HL
Macrophage-specific targeting of LXRs in CVD and NASH
$368,128Christopher K Glass · University Of California, San Diego · P01 · FY2022 · HL
Pivotal Role of Oxidation-specific Epitopes in CVD and NASH.
$368,126Joseph L Witztum · University Of California, San Diego · P01 · FY2022 · HL
High-Content Screening for Peroxisome Biogenesis for Type-II Diabetes.
$368,000Jonathan Zachary Sexton · North Carolina Central University · R01 · FY2011 · DK
Hypoxia-Inducible Factors in Liver Metabolism
$367,981Volker H. Haase · Vanderbilt University · R01 · FY2010 · DK
Regulation of Insulin sensitivity by Glucocorticoid-Angiopoietin-like 4-Ceramide Axis
$367,907Jen-Chywan Wang · University Of California Berkeley · R01 · FY2019 · DK
Modeling the Disease Burden and Cost-Effectiveness of Screening and Treatment for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Patients
$367,899Michael B Rothberg · Cleveland Clinic Foundation · R01 · FY2024 · HS
From Sugar to Fat: How the Transcription Factor XBP1 Regulates Hepatic Lipogenesi
$367,875Laurie H Glimcher · Harvard School Of Public Health · R01 · FY2010 · DK
Ang II and Overnutrition and Insulin resistance in Cardiovascular Tissue
$367,860James Russell Sowers · University Of Missouri-Columbia · R01 · FY2015 · HL
CEACAM1: A link between metabolic and cardiovascular diseases
$367,852Sonia Michael Najjar · University Of Toledo Health Sci Campus · R01 · FY2014 · HL